2020
DOI: 10.1186/s12920-020-0677-2
|View full text |Cite
|
Sign up to set email alerts
|

Convolutional neural network models for cancer type prediction based on gene expression

Abstract: BackgroundPrecise prediction of cancer types is vital for cancer diagnosis and therapy. Important cancer marker genes can be inferred through predictive model. Several studies have attempted to build machine learning models for this task however none has taken into consideration the effects of tissue of origin that can potentially bias the identification of cancer markers. ResultsIn this paper, we introduced several Convolutional Neural Network (CNN) models that take unstructured gene expression inputs to clas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
132
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
3
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 165 publications
(154 citation statements)
references
References 34 publications
3
132
0
1
Order By: Relevance
“…The average accuracy of this model was 95.59%. Mostavi et al [18] implemented three CNN models on the same datasets and achieved 95.7% accuracy for 33 tumour types and 95.0% accuracy for tumour types and normal samples. All of these studies only used gene expression data for pan-cancer classification without including complementary information from other types of omics data.…”
Section: Related Workmentioning
confidence: 99%
See 1 more Smart Citation
“…The average accuracy of this model was 95.59%. Mostavi et al [18] implemented three CNN models on the same datasets and achieved 95.7% accuracy for 33 tumour types and 95.0% accuracy for tumour types and normal samples. All of these studies only used gene expression data for pan-cancer classification without including complementary information from other types of omics data.…”
Section: Related Workmentioning
confidence: 99%
“…The average classification accuracy on different tumour types and normal samples (34 classes) achieved by the end-toend OmiVAE is 97.49% after 10-fold cross-validation and the standard deviation is 0.45%. As for the performance of other methods, only Mostavi et al [18] evaluated their model on the 34-class task for both tumour and normal samples with an accuracy of 95.0%. To further visualise the classification space learned by OmiVAE, we used t-SNE to reduce the dimension of latent vectors from 128 to 2 and plotted samples on a 2D scatter graph shown in Fig.…”
Section: B Supervised Phasementioning
confidence: 99%
“…Lyu et al [6] and Mostavi et al [17] embedded the RNA-Seq data from the PCA project into 2D images and trained a CNN to classify 33 tumor types, which outperforms the approach in [5]. Besides, they provide a functional analysis on the genes with high intensities in the HM based on GradCAM and validated that these top genes are related to tumor-specific pathways.…”
Section: Related Workmentioning
confidence: 99%
“…Deep Learning (DL) models have shown unprecedented success in a wide variety of applications ranging from classifying human brain signals to predicting sites of epitranscripome modifications [2,3]. In particular, Convolutional Neural Networks (CNNs) can be extremely beneficial in biological datasets not only by achieving high accuracy in predictive tasks but also by providing a clear explanation of the inner working process of the model [4,5]. Furthermore, automatic feature extraction in DL models is eliminating conventional human-made feature extraction methods that require a well-established prior knowledge about the biological problem of interest.…”
Section: Introductionmentioning
confidence: 99%